Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.
| Filed | Form | Activist | % of class | Conviction | |
|---|---|---|---|---|---|
| 2026-03-12 | SCHEDULE 13D/A | New Enterprise Associates 17, L.P. | 9.9% | Med | filing |
| Filed | Insider | Role | Shares | Value | |
|---|---|---|---|---|---|
| 2026-03-12 | Yang Rick (cluster of 9) | 10%-owner | 207,100 | $2,300,881 | Form 4 |
| 2026-03-12 | New Enterprise Associates 17, L.P. (cluster of 9) | 10%-owner | 207,100 | $2,300,881 | Form 4 |
| 2026-03-12 | SANDELL SCOTT D (cluster of 9) | 10%-owner | 207,100 | $2,300,881 | Form 4 |
| 2026-03-12 | Chang Carmen (cluster of 9) | 10%-owner | 207,100 | $2,300,881 | Form 4 |
| 2026-03-12 | BASKETT FOREST (cluster of 9) | 10%-owner | 207,100 | $2,300,881 | Form 4 |
| 2026-03-12 | Florence Anthony A. Jr. (cluster of 9) | 10%-owner | 207,100 | $2,300,881 | Form 4 |
| 2026-03-12 | Walker Paul Edward (cluster of 9) | 10%-owner | 207,100 | $2,300,881 | Form 4 |
| 2026-03-12 | Makhzoumi Mohamad (cluster of 9) | 10%-owner | 207,100 | $2,300,881 | Form 4 |
| 2026-03-12 | Mathers Edward T (cluster of 9) | 10%-owner | 207,100 | $2,300,881 | Form 4 |
from2028 — cross-site stock view. Rebuilt at publish time.